These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22568982)

  • 1. Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers.
    Conklin MW; Keely PJ
    Cell Adh Migr; 2012; 6(3):249-60. PubMed ID: 22568982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
    Giussani M; Merlino G; Cappelletti V; Tagliabue E; Daidone MG
    Semin Cancer Biol; 2015 Dec; 35():3-10. PubMed ID: 26416466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
    Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
    PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression.
    Saini H; Nikkhah M
    Methods Mol Biol; 2021; 2258():241-255. PubMed ID: 33340365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
    Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
    Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression.
    Gioiella F; Urciuolo F; Imparato G; Brancato V; Netti PA
    Adv Healthc Mater; 2016 Dec; 5(23):3074-3084. PubMed ID: 27925458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of heparins and nano-heparins as therapeutic tool in breast cancer.
    Afratis NA; Karamanou K; Piperigkou Z; Vynios DH; Theocharis AD
    Glycoconj J; 2017 Jun; 34(3):299-307. PubMed ID: 27778131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
    Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
    Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Holistic Appraisal of Stromal Differentiation in Colorectal Cancer: Biology, Histopathology, Computation, and Genomics.
    Hacking SM; Chakraborty B; Nasim R; Vitkovski T; Thomas R
    Pathol Res Pract; 2021 Apr; 220():153378. PubMed ID: 33690050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Whole Slide Image Analysis of Elevated Stromal Content and Extracellular Matrix Protein Expression Predicts Adverse Prognosis in Triple-Negative Breast Cancer.
    Karancsi Z; Gregus B; Krenács T; Cserni G; Nagy Á; Szőcs-Trinfa KF; Kulka J; Tőkés AM
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern views on the role of main components of stroma and tumor microinvironment in invasion, migration and metastasis.
    Naleskina LA; Kunska LM; Chekhun VF
    Exp Oncol; 2020 Dec; 42(4):252-262. PubMed ID: 33355867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic ruler to assess oncogenic transition between breast tumor and stroma.
    Dhage S; Ernlund A; Ruggles K; Axelrod D; Berman R; Roses D; Schneider RJ
    PLoS One; 2018; 13(10):e0205602. PubMed ID: 30325954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome.
    Reddy LA; Mikesh L; Moskulak C; Harvey J; Sherman N; Zigrino P; Mauch C; Fox JW
    J Proteome Res; 2014 Nov; 13(11):4739-51. PubMed ID: 25244421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
    Miller P; Kidwell KM; Thomas D; Sabel M; Rae JM; Hayes DF; Hudson BI; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2017 Nov; 166(1):85-94. PubMed ID: 28717852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of stromal decorin expression during the progression of breast cancer.
    Oda G; Sato T; Ishikawa T; Kawachi H; Nakagawa T; Kuwayama T; Ishiguro M; Iida S; Uetake H; Sugihara K
    Oncol Rep; 2012 Dec; 28(6):2003-8. PubMed ID: 22992875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer.
    McCart Reed AE; Song S; Kutasovic JR; Reid LE; Valle JM; Vargas AC; Smart CE; Simpson PT
    Virchows Arch; 2013 Oct; 463(4):535-45. PubMed ID: 23942617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.